The diagnosis and classification of amyopathic dermatomyositis: a historical review and assessment of existing criteria JSS Concha, M Tarazi, CJ Kushner, RG Gaffney, VP Werth British Journal of Dermatology 180 (5), 1001-1008, 2019 | 42 | 2019 |
Developing classification criteria for skin‐predominant dermatomyositis: the Delphi process JSS Concha, S Pena, RG Gaffney, B Patel, M Tarazi, CJ Kushner, ... British Journal of Dermatology 182 (2), 410-417, 2020 | 28 | 2020 |
Evaluation of the effectiveness and tolerability of mycophenolate mofetil and mycophenolic acid for the treatment of morphea M Arthur, NM Fett, E Latour, H Jacobe, E Kunzler, S Florez-Pollack, ... JAMA dermatology 156 (5), 521-528, 2020 | 26 | 2020 |
Cutaneous lupus erythematosus patients with a negative antinuclear antibody meeting the American College of Rheumatology and/or Systemic Lupus International Collaborating … M Tarazi, RG Gaffney, CJ Kushner, S Chakka, VP Werth Arthritis Care & Research 71 (11), 1404-1409, 2019 | 25 | 2019 |
Assessing the correlation between disease severity indices and quality of life measurement tools in pemphigus RL Krain, CJ Kushner, M Tarazi, RG Gaffney, AC Yeguez, DE Zamalin, ... Frontiers in immunology 10, 2571, 2019 | 21 | 2019 |
Auditory event-related potentials and function of the medial olivocochlear efferent system in children with auditory processing disorders T Morlet, K Nagao, LA Greenwood, RM Cardinale, RG Gaffney, T Riegner International journal of audiology 58 (4), 213-223, 2019 | 20 | 2019 |
Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in paediatric cutaneous lupus among paediatric … CJ Kushner, M Tarazi, RG Gaffney, R Feng, K Ardalan, ... British Journal of Dermatology 180 (1), 165-171, 2019 | 18 | 2019 |
Global teledermatology R Gaffney, B Rao Glob. Dermatol 2, 209-214, 2015 | 17 | 2015 |
Fatigue in systemic lupus erythematosus and other autoimmune skin diseases M Tarazi, RG Gaffney, D Pearson, CJ Kushner, VP Werth British Journal of Dermatology 180 (6), 1468-1472, 2019 | 14 | 2019 |
Examining cutaneous disease activity as an outcome measure for clinical trials in dermatomyositis RG Gaffney, R Feng, DR Pearson, M Tarazi, VP Werth Journal of the American Academy of Dermatology 80 (6), 1793-1794, 2019 | 10 | 2019 |
Cutaneous mucormycosis arising in the skin folds of immunocompromised patients: A case series R Rrapi, S Chand, R Gaffney, JA Lo, JS Smith, F Di Xia, ST Chen, ... JAAD Case Reports 17, 92-95, 2021 | 6 | 2021 |
Drug-induced dermatomyositis after lacosamide: A case report RG Gaffney, M Tarazi, VP Werth JAAD Case Reports 4 (6), 584-585, 2018 | 6 | 2018 |
Evaluating cutaneous lupus disease activity end points and their effects on quality of life as an outcome measure for clinical trials M Tarazi, RG Gaffney, R Feng, VP Werth British Journal of Dermatology 181 (4), 841-842, 2019 | 5 | 2019 |
A Retrospective Study of Calcinosis Cutis in Patients With Systemic Lupus Erythematosus. J Tiao, R Gaffney, F Fedeles Journal of Drugs in Dermatology: JDD 21 (10), 1137-1137, 2022 | 4 | 2022 |
Evaluating results of an interferon-γ release assay in patients with autoimmune disease who are taking hydroxychloroquine RG Gaffney, VP Werth Journal of the American Academy of Dermatology 80 (4), 1162-1164, 2019 | 4 | 2019 |
Treatment of recalcitrant lupus erythematosus tumidus with deucravacitinib A Zhang, RG Gaffney, JF Merola JAAD Case Reports 45, 110-112, 2024 | 2 | 2024 |
Cutaneous lupus erythematosus disease assessment: Highlighting CLE outcome measures RG Gaffney, VP Werth, JF Merola Frontiers in Medicine 9, 968469, 2022 | 2 | 2022 |
Rapid response of refractory subacute cutaneous lupus after single dose anifrolumab RG Gaffney, JF Merola JAAD Case Reports 44, 71-73, 2024 | 1 | 2024 |
A prospective cohort study comparing the performance of interferon gamma release assays in autoimmune skin diseases D Yan, R Gaffney, R Krain, E Keyes, JS Concha, R Feng, S Schulz, ... Journal of the American Academy of Dermatology 86 (4), 948-949, 2022 | 1 | 2022 |
AB002. Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in pediatric cutaneous lupus among pediatric … CJ Kushner, M Tarazi, RG Gaffney, R Feng, K Ardalan, ... Annals of Translational Medicine 7 (Suppl 4), AB002-AB002, 2019 | 1 | 2019 |